Wearable, noninvasive, pulsed shortwave (radiofrequency) therapy for postoperative analgesia: A randomized, double‐masked, sham‐controlled pilot study
Pain Practice · 2025
DOI: 10.1111/papr.70007 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pain Practice, 2025. Verfasst von Brian M Ilfeld und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, University California San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Postoperative Pain, Pulsed Radiofrequency Treatment, Wearable Electronic Devices, Pain Management. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of California, San Diego.
Abstract (Originalsprache)
Background
Nonthermal, pulsed shortwave (radiofrequency) therapy (PSWT) is a nonpharmacologic, noninvasive modality that limited evidence suggests provides analgesia. Its potential favorable risk–benefit ratio stems from its lack of side effects and significant medical risks, applicability to any anatomic location, long treatment duration, and ease of application by simply affixing it with tape. Even with a relatively small treatment effect, PSWT might contribute to a multimodal analgesic regimen, similar to acetaminophen. However, widespread clinical use is hindered by a lack of systematic evidence. The current randomized, controlled pilot study was undertaken to determine the feasibility and optimize the protocol for a subsequent definitive investigation and estimate the treatment effect of PSWT on postoperative pain and opioid consumption.
Methods
Within the recovery room following primary knee and hip arthroplasty, cholecystectomy, hernia repair, and non‐mastectomy breast surgery, we applied 1–3 PSWT devices (Model 088, BioElectronics Corporation, Frederick, Maryland) over the surgical bandages. Participants were randomized to 28 days of either active or sham treatment in a double‐masked fashion. The outcomes of primary interest were the cumulative opioid consumption and the mean of the “average” and “worst” daily pain measured with the Numeric Rating Scale over the first 7 postoperative days.
Results
During the first 7 postoperative days, oxycodone consumption in participants given active treatment ( n = 55) was a mean (SD) of 21 mg (24) versus 17 mg (26) in patients given sham ( n = 57): difference 4 (95% CI, −5 to 13), p = 0.376. During this same period, the “average” daily pain intensity in patients given active treatment was 2.4 (1.6) versus 2.6 (1.7) in sham: difference −0.2 (95% CI −0.8 to 0.5), p = 0.597. Concurrently, the worst/maximum pain for the active group was 4.6 (2.0) versus 4.7 (2.1) in sham: difference −0.1 (95% CI −0.8 to 0.7), p = 0.888. No device‐related systemic side effects or serious adverse events were identified.
Conclusions
Pulsed shortwave (radiofrequency) therapy did not reduce pain scores and opioid requirements to a statistically significant or clinically relevant degree during the initial postoperative week in this pilot study. These results must be replicated with a subsequent study before being considered definitive. Data from this preliminary study may be used to help plan future trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, University California San Diego, La Jolla, California, USA.
- The Outcomes Research Consortium, University of Texas, Houston, Houston, Texas.
- Department of Anesthesiology, University California San Diego, San Diego, California, USA.
- Department of Orthopedic Surgery, University California San Diego, San Diego, California, USA.
- Department of Surgery, University California San Diego, San Diego, California, USA.
- School of Medicine, University California San Diego, San Diego, California, USA.
ORCID-Profile: Brian M Ilfeld
Förderung
- University of California, San Diego
Zitieren
APA
Ilfeld, B. M., Finneran, J. J., Said, E. T., Ball, S. T., Wallace, A. M., Broderick, R. C., Sandler, B. J., Doucet, J. J., Hu, S. R., Cha, B. J., Murthy, A. N., & Abdullah, B. (2025). Wearable, noninvasive, pulsed shortwave (radiofrequency) therapy for postoperative analgesia: A randomized, double‐masked, sham‐controlled pilot study. Pain Practice. https://doi.org/10.1111/papr.70007
Vancouver
Ilfeld BM, Finneran JJ, Said ET, Ball ST, Wallace AM, Broderick RC, et al. Wearable, noninvasive, pulsed shortwave (radiofrequency) therapy for postoperative analgesia: A randomized, double‐masked, sham‐controlled pilot study. Pain Practice. 2025. doi:10.1111/papr.70007
BibTeX
@article{Ilfeld2025,
author = {Ilfeld, Brian M and Finneran, John J and Said, Engy T and Ball, Scott T and Wallace, Anne M and Broderick, Ryan C and Sandler, Bryan J and Doucet, Jay J and Hu, Sandy R and Cha, Brannon J and Murthy, Adhithi Narayana and Abdullah, Baharin},
title = {Wearable, noninvasive, pulsed shortwave (radiofrequency) therapy for postoperative analgesia: A randomized, double‐masked, sham‐controlled pilot study},
journal = {Pain Practice},
year = {2025},
doi = {10.1111/papr.70007}
}
EUVIMED